Showing results (11-20 of 696) with videos related to

Sort By:
Pageof 70
Current Opinion in Nephrology and Hypertension|October 11, 2019
Mitigating risk of aldosterone in diabetic kidney diseaseMarie Frimodt-Møller, Frederik Persson, Peter Rossing
Nephrologie & Therapeutique|April 3, 2018
Prognosis and treatment of diabetic nephropathy: Recent advances and perspectivesPeter Rossing, Frederik Persson, Marie Frimodt-Møller
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 5, 2016
Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic reviewFrederik Persson, Morten Lindhardt, Peter Rossing, et al.
Diabetes Technology & Therapeutics|April 25, 2012
Ambulatory tonometric blood pressure measurements in patients with diabetesSimone Theilade, Christel Joergensen, Frederik Persson, et al.
Diabetes|December 23, 2020
Linking Kidney and Cardiovascular Complications in Diabetes-Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award LecturePeter Rossing, Frederik Persson, Marie Frimodt-Møller, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 4, 2012
Discrepancy between tonometric ambulatory and cuff-based office blood pressure measurements in patients with type 1 diabetesSimone Theilade, Maria Lajer, Christel Joergensen, et al.
Diabetes Care|November 30, 2012
Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetesSimone Theilade, Maria Lajer, Frederik Persson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2022
Clinical implications and guidelines for CKD in type 2 diabetesRong M Zhang, Frederik Persson, Janet B McGill, et al.
Diabetes Care|October 30, 2008
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuriaCamilla Noelle Rathcke, Frederik Persson, Lise Tarnow, et al.
Journal of Diabetes and Its Complications|July 15, 2022
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk enginesElisabeth B Stougaard, Peter Rossing, David Cherney, et al.
Pageof 70